These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 9259074)

  • 1. Animal models for Chlamydia pneumoniae infection.
    Laitinen K; Alakärppä H; Laurila A; Leinonen M
    Scand J Infect Dis Suppl; 1997; 104():15-7. PubMed ID: 9259074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlamydia pneumoniae-induced atherosclerosis in a rabbit model.
    Muhlestein JB
    J Infect Dis; 2000 Jun; 181 Suppl 3():S505-7. PubMed ID: 10839748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo treatment of acute Chlamydia pneumoniae infection with the flavonoids quercetin and luteolin and an alkyl gallate, octyl gallate, in a mouse model.
    Törmäkangas L; Vuorela P; Saario E; Leinonen M; Saikku P; Vuorela H
    Biochem Pharmacol; 2005 Oct; 70(8):1222-30. PubMed ID: 16139801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis.
    Fong IW
    J Infect Dis; 2000 Jun; 181 Suppl 3():S514-8. PubMed ID: 10839750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse models of C. pneumoniae infection and atherosclerosis.
    Campbell LA; Blessing E; Rosenfeld M; Lin Tm; Kuo C
    J Infect Dis; 2000 Jun; 181 Suppl 3():S508-13. PubMed ID: 10839749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Establishment and experimental study on mouse model of Chlamydia pneumoniae pneumonitis].
    Shi Y; Yin J; Zhan H
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Oct; 24(10):592-5. PubMed ID: 11770419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Choice of antimicrobial drug for infections caused by Chlamydia trachomatis and Chlamydophila pneumoniae].
    Zele-Starcević L; Plecko V; Budimir A; Kalenić S
    Acta Med Croatica; 2004; 58(4):329-33. PubMed ID: 15700690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chlamydia pneumoniae chronic infection in the development of arteriosclerosis].
    Nalepa P
    Pol Merkur Lekarski; 1998 May; 4(23):289-91. PubMed ID: 9825666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlamydia pneumoniae and atherosclerosis.
    Ouchi K
    Jpn J Infect Dis; 1999 Dec; 52(6):223-7. PubMed ID: 10738358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis research.
    de Kruif MD; van Gorp EC; Keller TT; Ossewaarde JM; ten Cate H
    Cardiovasc Res; 2005 Feb; 65(2):317-27. PubMed ID: 15639470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia pneumoniae--an infectious risk factor for atherosclerosis?
    Campbell LA; Kuo CC
    Nat Rev Microbiol; 2004 Jan; 2(1):23-32. PubMed ID: 15035006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerosis and infection due to Chlamydia pneumoniae or cytomegalovirus: weighing the evidence.
    High KP
    Clin Infect Dis; 1999 Apr; 28(4):746-9. PubMed ID: 10825031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic and mucosal antibody response in experimental Chlamydia pneumoniae infection of mice.
    Penttilä T; Wahlström E; Vuola JM; Sarvas M; Puolakkainen M
    Comp Med; 2006 Aug; 56(4):272-8. PubMed ID: 16941954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenesis of Chlamydia pneumoniae-type pneumonitis in mice.
    Shi Y; Yin J; Zhan H; Feng G; Zhang X; Su X; Song Y; Xia X; Zhou X; Shen P
    Chin Med J (Engl); 2003 Mar; 116(3):328-32. PubMed ID: 12781030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Moazed TC; Campbell LA; Rosenfeld ME; Grayston JT; Kuo CC
    J Infect Dis; 1999 Jul; 180(1):238-41. PubMed ID: 10353889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chlamydia pneumoniae--chronic infection and atherosclerosis].
    Tiran B
    Wien Med Wochenschr; 2001; 151(24):590-3. PubMed ID: 11820175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivation of Chlamydia pneumoniae infection in mice by cortisone treatment.
    Laitinen K; Laurila AL; Leinonen M; Saikku P
    Infect Immun; 1996 Apr; 64(4):1488-90. PubMed ID: 8606126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a mouse lung challenge model to identify antigens protective against Chlamydia pneumoniae lung infection.
    Murdin AD; Dunn P; Sodoyer R; Wang J; Caterini J; Brunham RC; Aujame L; Oomen R
    J Infect Dis; 2000 Jun; 181 Suppl 3():S544-51. PubMed ID: 10839756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of simvastatin, an established lipid-lowering drug, on pulmonary Chlamydia pneumoniae infection in mice.
    Erkkilä L; Jauhiainen M; Laitinen K; Haasio K; Tiirola T; Saikku P; Leinonen M
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3959-62. PubMed ID: 16127082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlamydia pneumoniae and atherosclerosis.
    Campbell LA; Kuo CC
    Semin Respir Infect; 2003 Mar; 18(1):48-54. PubMed ID: 12652454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.